Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for (1 6)- d- glucan
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- Drug target sets for approved compounds
Most Relevant Literature
- Effects of starch type and concentration on the physicochemical properties of bilayer-stabilized oil…
- β(1-3)(1-6)-D-glucans modulate immune status in pigs: potential importance for efficiency of commerc…
- Effects of a dietary β-(1,3)(1,6)-D-glucan supplementation on intestinal microbial communities and i…
- Role of beta-(1→3)(1→6)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer c…
- The effect of oyster mushroom β-1.3/1.6-D-glucan and oxytetracycline antibiotic on biometrical, haem…
Most Relevant Clinical Trials
- Development The Potentiality of β-1,3/1,6-D-Glucan (Polysaccharide Peptide) From Mycelia Extract of …
- Effects of (1,3), (1,6)-Beta-D-glucan on Insulin Sensitivity and Inflammatory Markers of the Metabol…
- Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency Ulcers
- Host Modulatory Effects of β-glucan on Localized Aggressive Periodontitis
- A B-D-Glucan Driven Antifungal Stewardship Approach for Invasive Candidiasis
